Showing results (151-160 of 189) with videos related to

Sort By:
Pageof 19
Cancer Research|April 1, 1994
Transforming growth factor-alpha and endocrine sensitivity in breast cancerR I Nicholson, R A McClelland, J M Gee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosisR Hui, R D Macmillan, F S Kenny, et al.
International Journal of Cancer|August 22, 1995
Immunocytochemical localization of Fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapyJ M Gee, I O Ellis, J F Robertson, et al.
Breast Cancer Research and Treatment|January 1, 1994
Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapyR I Nicholson, R A McClelland, J M Gee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancerR Hui, A L Cornish, R A McClelland, et al.
British Journal of Cancer|July 4, 1998
Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapyR A McClelland, D L Manning, J M Gee, et al.
The International Journal of Biological Markers|September 30, 2000
The role of blood tumor marker measurement (using a biochemical index score and c-erbB2) in directing chemotherapy in metastatic breast cancerK L Cheung, S E Pinder, C Paish, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancerF S Kenny, R Hui, E A Musgrove, et al.
Histopathology|September 1, 1995
Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinomaH Pereira, S E Pinder, D M Sibbering, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 1997
Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancerC J Ormandy, R E Hall, D L Manning, et al.
Pageof 19